Skip to main content

Atorvastatin Protects NSC-34 Motor Neurons Against Oxidative Stress by Activating PI3K, ERK and Free Radical Scavenging

Abstract

Although statins, or hydroxymethylglutaryl coenzyme A (HMG-Co A) reductase inhibitors, are generally used to decrease levels of circulating cholesterol, they have also been reported to have neuroprotective effects through various mechanisms. However, recent results have indicated that they may be harmful in patients with amyotrophic lateral sclerosis (ALS). In this study, we investigate whether atorvastatin protects motor neuron-like cells (NSC-34D) from oxidative stress. To evaluate the effects of atorvastatin or hydrogen peroxide or both on NSC-34D cells, the cells were treated with various combinations of these agents. To evaluate the viability of the cells, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assays and trypan blue staining were performed. Levels of free radicals and intracellular signaling proteins were evaluated using the fluorescent probe 2′,7′-dichlorodihydrofluorescein diacetate (DCFH-DA) and Western blotting, respectively. Atorvastatin protected NSC-34D cells against oxidative stress in a concentration-dependent manner. This neuroprotective effect of atorvastatin was blocked by LY294002, a phosphatidylinositol 3-kinase (PI3K) inhibitor and by FR180204, a selective extracellular signal-related kinase (ERK) inhibitor. Atorvastatin treatment increased the expression levels of p85αPI3K, phosphorylated Akt, phosphorylated glycogen synthase kinase-3β, phosphorylated ERK, and Bcl-2, which are proteins related to survival. Furthermore, atorvastatin decreased the levels of cytosolic cytochrome C, Bax, cleaved caspase-9, and cleaved caspase-3, which are associated with death in oxidative stress-injured NSC-34D cells. We conclude that atorvastatin has a protective effect against oxidative stress in motor neurons by activating the PI3K and ERK pathways as well as by scavenging free radicals. These findings indicate that statins could help protect motor neurons from oxidative stress.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

References

  1. Stein EA (2002) Management of dyslipidemia in the high-risk patient. Am Heart J 144(6 Suppl):S43–S50. doi:10.1067/mhj.2002.130302

    CAS  Article  PubMed  Google Scholar 

  2. Sakabe K, Fukuda N, Wakayama K, Nada T, Shinohara H, Tamura Y (2004) Lipid-altering changes and pleiotropic effects of atorvastatin in patients with hypercholesterolemia. Am J Cardiol 94(4):497–500. doi:10.1016/j.amjcard.2004.04.067

    CAS  Article  PubMed  Google Scholar 

  3. Wahner AD, Bronstein JM, Bordelon YM, Ritz B (2008) Statin use and the risk of Parkinson disease. Neurology 70(16 Pt 2):1418–1422. doi:10.1212/01.wnl.0000286942.14552.51

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  4. Eckert GP, Wood WG, Muller WE (2005) Statins: drugs for Alzheimer’s disease? J Neural Transm 112(8):1057–1071. doi:10.1007/s00702-004-0273-1

    CAS  Article  PubMed  Google Scholar 

  5. Neuhaus O, Hartung HP (2007) Evaluation of atorvastatin and simvastatin for treatment of multiple sclerosis. Expert Rev Neurother 7(5):547–556. doi:10.1586/14737175.7.5.547

    CAS  Article  PubMed  Google Scholar 

  6. Wible EF, Laskowitz DT (2010) Statins in traumatic brain injury. Neurother : J Am Soc Exp Neurother 7(1):62–73. doi:10.1016/j.nurt.2009.11.003

    CAS  Article  Google Scholar 

  7. Edwards IR, Star K, Kiuru A (2007) Statins, neuromuscular degenerative disease and an amyotrophic lateral sclerosis-like syndrome: an analysis of individual case safety reports from vigibase. Drug Saf : Int J Med Toxicol Drug Exp 30(6):515–525

    Article  Google Scholar 

  8. Colman E, Szarfman A, Wyeth J, Mosholder A, Jillapalli D, Levine J, Avigan M (2008) An evaluation of a data mining signal for amyotrophic lateral sclerosis and statins detected in FDA’s spontaneous adverse event reporting system. Pharmacoepidemiol Drug Saf 17(11):1068–1076. doi:10.1002/pds.1643

    Article  PubMed  Google Scholar 

  9. Zinman L, Sadeghi R, Gawel M, Patton D, Kiss A (2008) Are statin medications safe in patients with ALS? Amyotroph Lateral Scler : Off Publ World Fed Neurol Res Group Mot Neuron Dis 9(4):223–228. doi:10.1080/17482960802031092

    CAS  Article  Google Scholar 

  10. Drory VE, Bronipolsky T, Artamonov I, Nefussy B (2008) Influence of statins treatment on survival in patients with amyotrophic lateral sclerosis. J Neurol Sci 273(1–2):81–83. doi:10.1016/j.jns.2008.06.022

    CAS  Article  PubMed  Google Scholar 

  11. Iwamoto K, Yoshii Y, Ikeda K (2009) Atorvastatin treatment attenuates motor neuron degeneration in Wobbler mice. Amyotroph Lateral Scler: Off Publ World Fed Neurol Res Group Mot Neuron Dis 10(5–6):405–409. doi:10.3109/17482960902870993

    CAS  Article  Google Scholar 

  12. Cashman NR, Durham HD, Blusztajn JK, Oda K, Tabira T, Shaw IT, Dahrouge S, Antel JP (1992) Neuroblastoma x spinal cord (NSC) hybrid cell lines resemble developing motor neurons. Dev Dyn : Off Publ Am Assoc Anat 194(3):209–221. doi:10.1002/aja.1001940306

    CAS  Article  Google Scholar 

  13. Eggett CJ, Crosier S, Manning P, Cookson MR, Menzies FM, McNeil CJ, Shaw PJ (2000) Development and characterisation of a glutamate-sensitive motor neuron cell line. J Neurochem 74(5):1895–1902

    CAS  Article  PubMed  Google Scholar 

  14. Hemendinger RA, Armstrong EJ 3rd, Radio N, Brooks BR (2012) Neurotoxic injury pathways in differentiated mouse motor neuron-neuroblastoma hybrid (NSC-34D) cells in vitro—limited effect of riluzole on thapsigargin, but not staurosporine, hydrogen peroxide and homocysteine neurotoxicity. Toxicol Appl Pharmacol 258(2):208–215. doi:10.1016/j.taap.2011.10.022

    CAS  Article  PubMed  Google Scholar 

  15. Cantrell DA (2001) Phosphoinositide 3-kinase signalling pathways. J Cell Sci 114(Pt 8):1439–1445

    CAS  PubMed  Google Scholar 

  16. Cantley LC (2002) The phosphoinositide 3-kinase pathway. Science 296(5573):1655–1657. doi:10.1126/science.296.5573.1655

    CAS  Article  PubMed  Google Scholar 

  17. Cookson MR, Shaw PJ (1999) Oxidative stress and motor neurone disease. Brain Pathol 9(1):165–186

    CAS  Article  PubMed  Google Scholar 

  18. Kim YS, Noh MY, Kim JY, Yu HJ, Kim KS, Kim SH, Koh SH (2013) Direct GSK-3beta inhibition enhances mesenchymal stromal cell migration by increasing expression of beta-PIX and CXCR4. Mol Neurobiol 47(2):811–820. doi:10.1007/s12035-012-8393-3

    CAS  Article  PubMed  Google Scholar 

  19. Vanhaesebroeck B, Waterfield MD (1999) Signaling by distinct classes of phosphoinositide 3-kinases. Exp Cell Res 253(1):239–254. doi:10.1006/excr.1999.4701

    CAS  Article  PubMed  Google Scholar 

  20. Smith MA, Perry G, Richey PL, Sayre LM, Anderson VE, Beal MF, Kowall N (1996) Oxidative damage in Alzheimer’s. Nature 382(6587):120–121. doi:10.1038/382120b0

    CAS  Article  PubMed  Google Scholar 

  21. van der Most PJ, Dolga AM, Nijholt IM, Luiten PG, Eisel UL (2009) Statins: mechanisms of neuroprotection. Prog Neurobiol 88(1):64–75. doi:10.1016/j.pneurobio.2009.02.002

    Article  PubMed  Google Scholar 

  22. Bosel J, Gandor F, Harms C, Synowitz M, Harms U, Djoufack PC, Megow D, Dirnagl U, Hortnagl H, Fink KB, Endres M (2005) Neuroprotective effects of atorvastatin against glutamate-induced excitotoxicity in primary cortical neurones. J Neurochem 92(6):1386–1398. doi:10.1111/j.1471-4159.2004.02980.x

    Article  PubMed  Google Scholar 

  23. Wang J, Tokoro T, Matsui K, Higa S, Kitajima I (2005) Pitavastatin at low dose activates endothelial nitric oxide synthase through PI3K-AKT pathway in endothelial cells. Life Sci 76(19):2257–2268. doi:10.1016/j.lfs.2004.12.003

    CAS  Article  PubMed  Google Scholar 

  24. Dimmeler S, Aicher A, Vasa M, Mildner-Rihm C, Adler K, Tiemann M, Rutten H, Fichtlscherer S, Martin H, Zeiher AM (2001) HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. J Clin Invest 108(3):391–397. doi:10.1172/JCI13152

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  25. Zipp F, Waiczies S, Aktas O, Neuhaus O, Hemmer B, Schraven B, Nitsch R, Hartung HP (2007) Impact of HMG-CoA reductase inhibition on brain pathology. Trends Pharmacol Sci 28(7):342–349. doi:10.1016/j.tips.2007.05.001

    CAS  Article  PubMed  Google Scholar 

  26. Wagner AH, Kohler T, Ruckschloss U, Just I, Hecker M (2000) Improvement of nitric oxide-dependent vasodilatation by HMG-CoA reductase inhibitors through attenuation of endothelial superoxide anion formation. Arterioscler Thromb Vasc Biol 20(1):61–69

    CAS  Article  PubMed  Google Scholar 

  27. Weitz-Schmidt G, Welzenbach K, Brinkmann V, Kamata T, Kallen J, Bruns C, Cottens S, Takada Y, Hommel U (2001) Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site. Nat Med 7(6):687–692. doi:10.1038/89058

    CAS  Article  PubMed  Google Scholar 

  28. Wood WG, Igbavboa U, Muller WE, Eckert GP (2013) Statins, Bcl-2, and apoptosis: cell death or cell protection? Mol Neurobiol 48(2):308–314. doi:10.1007/s12035-013-8496-5

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  29. Spampanato C, De Maria S, Sarnataro M, Giordano E, Zanfardino M, Baiano S, Carteni M, Morelli F (2012) Simvastatin inhibits cancer cell growth by inducing apoptosis correlated to activation of Bax and down-regulation of BCL-2 gene expression. Int J Oncol 40(4):935–941. doi:10.3892/ijo.2011.1273

    CAS  PubMed  Google Scholar 

  30. Yu X, Pan Y, Ma H, Li W (2013) Simvastatin inhibits proliferation and induces apoptosis in human lung cancer cells. Oncol Res 20(8):351–357. doi:10.3727/096504013X13657689382897

    CAS  Article  PubMed  Google Scholar 

  31. Johnson-Anuna LN, Eckert GP, Franke C, Igbavboa U, Muller WE, Wood WG (2007) Simvastatin protects neurons from cytotoxicity by up-regulating Bcl-2 mRNA and protein. J Neurochem 101(1):77–86. doi:10.1111/j.1471-4159.2006.04375.x

    CAS  Article  PubMed  Google Scholar 

  32. Franke C, Noldner M, Abdel-Kader R, Johnson-Anuna LN, Gibson Wood W, Muller WE, Eckert GP (2007) Bcl-2 upregulation and neuroprotection in guinea pig brain following chronic simvastatin treatment. Neurobiol Dis 25(2):438–445. doi:10.1016/j.nbd.2006.10.004

    CAS  Article  PubMed  Google Scholar 

  33. Grewal SS, York RD, Stork PJ (1999) Extracellular-signal-regulated kinase signalling in neurons. Curr Opin Neurobiol 9(5):544–553. doi:10.1016/S0959-4388(99)00010-0

    CAS  Article  PubMed  Google Scholar 

  34. Kim S, Lee KY, Koh SH, Park HH, Yu HJ, Lee YJ (2012) Role of the phosphatidylinositol 3-kinase and extracellular signal-regulated kinase pathways in the neuroprotective effects of cilnidipine against hypoxia in a primary culture of cortical neurons. Neurochem Int 61(7):1172–1182. doi:10.1016/j.neuint.2012.08.010

    CAS  Article  PubMed  Google Scholar 

  35. Hetman M, Xia Z (2000) Signaling pathways mediating anti-apoptotic action of neurotrophins. Acta Neurobiol Exp 60(4):531–545

    CAS  Google Scholar 

  36. Fridovich I (1975) Superoxide dismutases. Annu Rev Biochem 44:147–159. doi:10.1146/annurev.bi.44.070175.001051

    CAS  Article  PubMed  Google Scholar 

  37. Forsberg K, Andersen PM, Marklund SL, Brannstrom T (2011) Glial nuclear aggregates of superoxide dismutase-1 are regularly present in patients with amyotrophic lateral sclerosis. Acta Neuropathol 121(5):623–634. doi:10.1007/s00401-011-0805-3

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  38. Barber SC, Mead RJ, Shaw PJ (2006) Oxidative stress in ALS: a mechanism of neurodegeneration and a therapeutic target. Biochim Biophys Acta 1762(11–12):1051–1067. doi:10.1016/j.bbadis.2006.03.008

    CAS  Article  PubMed  Google Scholar 

  39. Forman HJ, Maiorino M, Ursini F (2010) Signaling functions of reactive oxygen species. Biochemistry 49(5):835–842. doi:10.1021/bi9020378

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  40. Stone JR, Yang S (2006) Hydrogen peroxide: a signaling messenger. Antioxid Redox Signal 8(3–4):243–270. doi:10.1089/ars.2006.8.243

    CAS  Article  PubMed  Google Scholar 

  41. Li Q, Spencer NY, Pantazis NJ, Engelhardt JF (2011) Alsin and SOD1(G93A) proteins regulate endosomal reactive oxygen species production by glial cells and proinflammatory pathways responsible for neurotoxicity. J Biol Chem 286(46):40151–40162. doi:10.1074/jbc.M111.279711

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  42. Tanaka T, Tatsuno I, Uchida D, Moroo I, Morio H, Nakamura S, Noguchi Y, Yasuda T, Kitagawa M, Saito Y, Hirai A (2000) Geranylgeranyl-pyrophosphate, an isoprenoid of mevalonate cascade, is a critical compound for rat primary cultured cortical neurons to protect the cell death induced by 3-hydroxy-3-methylglutaryl-CoA reductase inhibition. J Neurosci 20(8):2852–2859

    CAS  PubMed  Google Scholar 

  43. García-Román N, Alvarez AM, Toro MJ, Montes A, Lorenzo MJ (2001) Lovastatin induces apoptosis of spontaneously immortalized rat brain neuroblasts: involvement of nonsterol isoprenoid biosynthesis inhibition. Mol Cell Neurosci 17(2):329–341

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by a grant from the Korea Research Foundation (2012R1A1B3000473) and a grant from the NanoBio R&D Program of the Korea Science and Engineering Foundation, funded by the Ministry of Education, Science and Technology (2007–04717).

Conflict of Interest

None.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Young Joo Lee or Seong-Ho Koh.

Additional information

Seok-Ho Lee, Na-Young Choi, and Hyun-Jeung Yu contributed equally to this work.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Lee, SH., Choi, NY., Yu, HJ. et al. Atorvastatin Protects NSC-34 Motor Neurons Against Oxidative Stress by Activating PI3K, ERK and Free Radical Scavenging. Mol Neurobiol 53, 695–705 (2016). https://doi.org/10.1007/s12035-014-9030-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12035-014-9030-0

Keywords

  • Statin
  • Amyotrophic lateral sclerosis
  • Phosphatidylinositol 3-kinase
  • Extracellular signal-related kinase